KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares Repurchased
Ratios

Gilead Sciences (GILD) Accumulated Depreciation & Amortization (2016 - 2025)

Gilead Sciences (GILD) has disclosed Accumulated Depreciation & Amortization for 17 consecutive years, with $2.6 billion as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Accumulated Depreciation & Amortization changed N/A year-over-year to $2.6 billion, compared with a TTM value of $2.6 billion through Jun 2025, changed N/A, and an annual FY2024 reading of $2.5 billion, up 0.86% over the prior year.
  • Accumulated Depreciation & Amortization was $2.6 billion for Q2 2025 at Gilead Sciences, up from $2.5 billion in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $2.6 billion in Q2 2025 and bottomed at $1.9 billion in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $2.3 billion, with a median of $2.4 billion recorded in 2023.
  • The sharpest move saw Accumulated Depreciation & Amortization rose 15.48% in 2022, then increased 0.86% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $1.9 billion in 2021, then rose by 15.48% to $2.2 billion in 2022, then increased by 12.03% to $2.4 billion in 2023, then rose by 0.86% to $2.5 billion in 2024, then rose by 6.11% to $2.6 billion in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for GILD at $2.6 billion in Q2 2025, $2.5 billion in Q4 2024, and $2.4 billion in Q4 2023.